ArticleAntonie van Leeuwenhoek2025
Factors influencing antifungal activity of selected lactic acid bacteria strains and characterization of their active compounds.
Article in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Lactic acid bacteria (LAB) are known to possess potent antifungal activity; however, the factors that affect this activity remain poorly investigated. In this study, we explored the influence of physicochemical and nutritional factors on the antifungal activity of five LAB strains namely Lactiplantibacillus pentosus 22B, Leuconostoc mesenteroides 8C2, Lactiplantibacillus plantarum 21B, Enterococcus faecium LC2V5 and Enterococcus faecium LC2P8. These factors included incubation period, medium initial pH, incubation temperature, long-term storage and carbon source. Results showed that these factors significantly influenced the antifungal activity of the studied LAB strains (p < 0.0001). The optimal conditions yielding the most potent inhibition (21 ± 0.4 mm to 19 ± 0.4 mm) were identified. Specifically, maximum activity was achieved after a 48-h incubation (late stationary phase), at 25-30 °C, an initial pH of 3-4, and with sucrose, galactose, or mannose as the carbon source, depending on the strain. Moreover, long-term storage at - 80 °C led to complete loss of activity in two strains (8C2 and LC2P8), while the other three remained stable. Furthermore, HPLC and GC-MS analyses were used to identify the antifungal compounds produced by these three stable strains. The results revealed the presence of various organic acids (lactic, acetic, formic, malic, and fumaric acids) and fatty acids, such as 9-octadecenoic acid, 11-dodecenoic acid, 10-hydroxy. Scanning electron microscopy confirmed that these compounds caused significant structural damage to fungal mycelia, supporting their demonstrated fungicidal effects. This study improves our understanding of the key factors and mechanisms underlying LAB antifungal activity, contributing to the optimization of their use as natural antifungal agents.
Indexed as
Identifiers
41402555What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.